Mass Spec Enables More Definitive Biologics Drug Discovery and Optimization
The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as post-translational modifications (PTMs) and sequence variants can affect product quality, safety, and efficacy.
Mass Spec (MS) has emerged as a powerful tool for structure and function analysis with unmatched precision and high-throughput (HTP) capabilities.
- HTP Intact Mass
- Peptide mapping
- Glycan analysis
This webinar will showcase advanced MS methodologies for both qualitative physicochemical characterization and quantitative analysis for target validation and PK assessment.
No additional quotes available.
Author's summary: Mass Spec enhances biologics discovery.